Inactive Instrument

Other languages Spatializer Audio Laboratories, Inc. Other OTC

Equities

US84725L3096

End-of-day quote Other OTC Other stock markets
- ^USD	-

Mar. 26	Enveric Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 19	Sector Update: Health Care Stocks Rise Late Afternoon	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Enveric Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 26
Sector Update: Health Care Stocks Rise Late Afternoon	Mar. 19
Sector Update: Health Care Stocks Higher in Tuesday Afternoon Trading	Mar. 19
Enveric Biosciences Signs Licensing Term Sheets for Joint Disease Treatment Compounds; Shares Rise	Mar. 19
Wall Street Set to Open Lower Ahead of Two-Day Fed Meeting; Housing Starts Surge Higher Than Expected	Mar. 19
Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of New Chemical Entities for Pharmaceutical and Non-Pharmaceutical Applications in Joint Disease	Mar. 19
Enveric Biosciences Issues 228,690 Shares in Direct Offering	Mar. 11
Top Midday Gainers	Feb. 29
Wall Street Set to Open Higher Thursday as Inflation Data Meets Forecasts	Feb. 29
Investors Await Slate of Economic Data as US Futures Move Lower in Thursday's Premarket Session	Feb. 29
Sector Update: Health Care Stocks Rise in Late Afternoon	Feb. 23
Sector Update: Health Care Stocks Advance Friday Afternoon	Feb. 23
Enveric Biosciences Surging on Plans to Sell Cannabinoid IP Portfolio, Focus Shift to Psilocin Therapies	Feb. 23
Enveric Biosciences Unveils Library of Preclinical Compounds Across Multiple Distinct Molecule Classes Targeting Mental Health Disorders	Feb. 21
Enveric Biosciences Updates Key Data Underpinning Selection of EB-003 as Lead Drug Candidate from EVM301 Series	Jan. 03
Enveric Bioscience Generates $1.8 Million as Investors Exercise Warrants	Dec. 29
Sector Update: Health Care Stocks Rise in Late Afternoon	Dec. 28
Enveric Biosciences Selects EB-003 as Lead Drug Candidate from EVM301 Series	Dec. 28
Enveric Biosciences Selects EB-003 as Lead Drug Candidate to Treat Mental Health Disorders	Dec. 28
Enveric Biosciences Selects Development Candidates from Evm301 Series Based on Potential to Minimize or Eliminate the Hallucinogenic Effect of Psychedelic-Derived Compounds	Dec. 05

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Spatializer Audio Laboratories, Inc. Other OTC

Equities

US84725L3096

Other languages

Filters